These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8016389)

  • 1. Biochemical and pharmacological activity of arene-fused prostacyclin analogues on human platelets.
    Jakubowski JA; Utterback BG; Mais DE; Hardinger SA; Braish TF; Nevill CR; Fuchs PL
    Prostaglandins; 1994 Mar; 47(3):189-201. PubMed ID: 8016389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological properties of the new stable prostacyclin analogue 3-Oxa-methano-prostaglandin I.
    Yamamoto T; Satoh K; Nishimura T; Horikawa N; Mine T; Hirohashi T; Hara Y
    Arzneimittelforschung; 1994 Apr; 44(4):483-90. PubMed ID: 8011001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of TRK-100, a stable prostacyclin analogue, on regulation of cyclic AMP metabolism in platelets.
    Nogimori K; Kajikawa N; Nishio S; Yajima M
    Prostaglandins; 1989 Feb; 37(2):205-12. PubMed ID: 2543034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiating effect of 3-isobutyryl-2-isopropylpyrazolo-[1,5a]-pyridine (KC-404), a new cerebral vasodilator with anti-platelet activity, on prostacyclin-induced increase of cyclic AMP content in platelets of rat.
    Hisayama T; Takayanagi I; Goromaru N; Okamoto Y
    Gen Pharmacol; 1989; 20(2):183-6. PubMed ID: 2541044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
    Armstrong RA; Jones RL; MacDermot J; Wilson NH
    Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet rap1B phosphorylation is a sensitive marker for the action of cyclic AMP- and cyclic GMP-increasing platelet inhibitors and vasodilators.
    Grünberg B; Kruse HJ; Negrescu EV; Siess W
    J Cardiovasc Pharmacol; 1995 Apr; 25(4):545-51. PubMed ID: 7596121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
    Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet receptor desensitization induced by elevated prostacyclin levels causes platelet-endothelial cell adhesion.
    Darius H; Binz C; Veit K; Fisch A; Meyer J
    J Am Coll Cardiol; 1995 Sep; 26(3):800-6. PubMed ID: 7543911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
    Corsini A; Folco GC; Fumagalli R; Nicosia S; Noe MA; Oliva D
    Br J Pharmacol; 1987 Jan; 90(1):255-61. PubMed ID: 3545351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human prostacyclin platelet receptors in diabetes mellitus.
    Modesti PA; Fortini A; Gensini GF; Vanni D; Prisco D; Abbate R
    Thromb Res; 1991 Sep; 63(5):541-8. PubMed ID: 1755006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships associated with 3,4,5-triphenyl-1H-pyrazole-1-nonanoic acid, a nonprostanoid prostacyclin mimetic.
    Meanwell NA; Rosenfeld MJ; Wright JJ; Brassard CL; Buchanan JO; Federici ME; Fleming JS; Seiler SM
    J Med Chem; 1992 Jan; 35(2):389-97. PubMed ID: 1370696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Iloprost, Cicaprost and prostacyclin effects on cyclic AMP metabolism in intact platelets.
    Ashby B
    Prostaglandins; 1992 Mar; 43(3):255-61. PubMed ID: 1378640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.
    Jones RL; Qian YM; Wise H; Wong HN; Lam WL; Chan HW; Yim AP; Ho JK
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):525-35. PubMed ID: 9156364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostacyclin-sensitive adenylate cyclase and prostacyclin binding sites in platelets and smooth muscle cells.
    Nicosia S; Oliva D; Bernini F; Fumagalli R
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():593-9. PubMed ID: 6328938
    [No Abstract]   [Full Text] [Related]  

  • 19. (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.
    Corsini A; Oliva D; Folco GC; Giovanazzi S; Noe' MA; Fumagalli R; Nicosia S
    Biomed Biochim Acta; 1988; 47(10-11):S104-7. PubMed ID: 3073757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on antiplatelet effects of OP-41483, a prostaglandin I2 analog, in experimental animals. II. Mechanism of its antiplatelet effect.
    Fujitani B; Wakitani K
    Jpn J Pharmacol; 1990 May; 53(1):25-33. PubMed ID: 2161965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.